Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
June 6 (Reuters) - Onxeo SA ALONX.PA :
* ONXEO CHANGES ITS NAME AND BECOMES VALERIO THERAPEUTICS FOLLOWING APPROVAL
BY
THE ANNUAL GENERAL MEETING OF JUNE 6, 2023
Source text for Eikon: ID:nBwtXYFta
Further company coverage: ALONX.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln